These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453 [TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation. Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544 [TBL] [Abstract][Full Text] [Related]
4. Interventions for preventing silent cerebral infarcts in people with sickle cell disease. Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860 [TBL] [Abstract][Full Text] [Related]
5. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria. Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630 [No Abstract] [Full Text] [Related]
6. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews. Fortin PM; Hopewell S; Estcourt LJ Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867 [TBL] [Abstract][Full Text] [Related]
7. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083 [TBL] [Abstract][Full Text] [Related]
8. Current management of sickle cell anemia. McGann PT; Nero AC; Ware RE Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23709685 [TBL] [Abstract][Full Text] [Related]
9. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851 [TBL] [Abstract][Full Text] [Related]
10. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555 [TBL] [Abstract][Full Text] [Related]
11. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Wang WC; Dwan K Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646 [TBL] [Abstract][Full Text] [Related]
12. Interventions for chronic kidney disease in people with sickle cell disease. Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087 [TBL] [Abstract][Full Text] [Related]
17. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Chaturvedi S; DeBaun MR Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630 [TBL] [Abstract][Full Text] [Related]
18. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Mazumdar M; Heeney MM; Sox CM; Lieu TA Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181 [TBL] [Abstract][Full Text] [Related]
19. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease. Mack AK; Thompson AA J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528 [TBL] [Abstract][Full Text] [Related]
20. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Kassim AA; DeBaun MR Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]